| Name | Title | Contact Details |
|---|
Avaxia is a leader in the growing field of gut-targeted therapeutics — orally administered, minimally absorbed drugs that are designed to act locally in the gastrointestinal tract. Avaxia’s lead clinical candidate, AVX-470, is an oral anti-TNF antibody for inflammatory bowel disease. This transformative product offers potentially improved safety and efficacy over existing anti-TNF therapies by focusing immune suppression only where needed in the diseased gut. Avaxia plans to use its gut-targeted antibody platform to develop therapeutics to address many other serious diseases such as type 2 diabetes, celiac disease, GI acute radiation syndrome and oral mucositis.
Polyzen develops and manufactures disposable medical products and devices for medical industry original equipment manufacturers.
Palo Pinto General Hospital is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Palo Pinto General Hospital is based in Mineral Wells, TX. You can find more information on Palo Pinto General Hospital at www.ppgh.com
Freedom Health, Inc. is a Tampa, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Leverage our resources to scale your practice, while maintaining your independence.